ERT Archives - CDR – Chain Drug Review

ERT study indicates swift adoption of virtual clinical trials due to COVID-19

June 3, 2020 by Chain Drug Review COVID-19, ERT, Jim Mahon, Virtual Trials and the COVID-19 Pandemic: The State of the Industry Leading Headlines, Pharmacy

PHILADELPHIA – ERT, the global leader in clinical endpoints data collection, announced the results of a recent industry survey that indicate an acceleration in the adoption of virtual clinical trials due to the COVID-19 pandemic. According to the survey report, ‘Virtual Trials and the COVID-19 Pandemic: The State of the Industry,” 82% of clinical trial

ERT partners to help improve health outcomes

May 9, 2018 by Chain Drug Review Alex Butler, ERT, Foundry3, Tim Davis Technology

PHILADELPHIA – ERT, a global data and technology company dedicated to improving health outcomes through innovative drug development and patient support solutions, and Foundry3, a creative, science and innovation agency, today announced a partnership to create tailored digital health programs that improve clinical outcomes by providing support to patients throughout their health care journeys. The